# Peptris Technologies Private

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/peptris-technologies-private

- Industry: Biotechnology
- Headquarters: Bangalore, India
- Website: www.peptris.com
- Total disclosed funding: $7.7M
- Latest round: Series A (Feb 18, 2026)
- Investors on record: 4

## About

Based in Bangalore, India, and founded in 2019, Peptris Technologies Private Limited develops therapeutic solutions for treating medical conditions like cancer using biotechnology and artificial intelligence like machine learning. As of 2023, the company is led by Venkatasubramanian (CEO). In February 2026, Peptris Technologies Private Limited raised INR 700 million in series A funding from Indian Angel Network, Speciale Invest, Tenacity Ventures, BYT Capital.

The company focuses on oncology, inflammation, and rare diseases. They have developed a machine learning platform to predict small-molecule-protein and protein-protein interactions. The platform can predict interactions for 100 million assays in a day with accuracy rivaling AI/ML small molecules de-novo molecule design. 

The company will use the February 2026 funding to advance existing programs toward clinical readiness and to expand its drug discovery pipeline over the next 24 months.

## Funding rounds

- Series A, Feb 18, 2026, $7.7M — Indian Angel Network, Speciale Invest, Tenacity Ventures, BYT Capital

## Investors

- Indian Angel Network (https://capitalatlas.ai/funds/indian-angel-network) — Series A
- Speciale Invest (https://capitalatlas.ai/funds/speciale-invest) — Series A
- Tenacity Ventures (https://capitalatlas.ai/funds/tenacity-ventures) — Series A
- BYT Capital (https://capitalatlas.ai/funds/byt-capital) — Series A